Skip to main content

Specialty Pharmacy

  • Gilead honors Camber parent company Hetero Drugs

    PISCATAWAY, N.J. — Camber Pharmaceuticals announced Wednesday that its parent company, Hetero Drugs, has been recognized by Gilead Sciences for its work providing access to hepatitis C drugs for patients worldwide. Hetero markets sofosbuvir  as Sofovir and ledipasvir-sofosbuvir as Ledifos in India and will eventually reach some 91 countries. The two drugs are better known in the United States and as Sovaldi and Harvoni. 
     
    In India, an estimated 12 million to 18 million patients are infected with hepatitis C. 

  • Pfizer announces availability of Inflectra, its Remicade biosimilar

    NEW YORK — Pfizer on Tuesday announced that it will begin shipping its Inflectra (infliximab-dyyb), a biosimilar of Remicade (infliximab), to U.S. wholesalers starting at the end of November. 
     
    Inflectra will be the second biosimilar available in the United States, and the first biosimilar monoclonal antibody. Pfizer will introduce Inflectra at a 15% discount to the current wholesaler acquisition cost of Remicade.
     

  • Despite 2015 slowdown, specialty continues to grow share of health spend

    For the year ended May 2016, specialty medicines made up 36% of all drug spend, according to IMS Health data. And for the year-to-date as of May, specialty spending growth was at 23% — outpacing the 7.8% YTD spending growth that traditional medicines saw in the same time period.

  • Diplomat rolls out campaign celebrating American Pharmacists Month

  • Lupin, MonoSol Rx ink licensing agreement for pediatric products

    WARREN, New Jersey, BALTIMORE and MUMBAI — Lupin on Tuesday announced a new strategic licensing agreement with specialty pharmaceutical company MonoSol Rx. Under the agreement, Lupin would develop multiple pediatric products using Monosol Rx’s PharmFilm drug delivery technology. 
     

  • Teva, Celltrion partner on biosimilar commercialization

    JERUSALEM and INCHEON, South Korea — Teva and Celltrion on Thursday announced a new exclusive partnership centered on commercializing two of Celltrion’s biosimilar candidates in the United States and Canada. 
     

  • Thrifty White gets URAC specialty pharmacy accreditation

    PLYMOUTH, Minn. — Thrifty White Pharmacy recently announced that it had received specialty pharmacy accreditation from the URAC, the Washington, D.C.-based health care accreditation organization. 
     

  • Walgreens collaborates with NASP, ProCE on specialty pharmacist education

    WASHINGTON — At the first full day of the National Association of Specialty Pharmacy’s Annual Meeting & Expo, Walgreens announced a collaboration with NASP and continuing pharmacy and medical education company ProCE on a web-based continuing education (CE) center for Walgreens Specialty Pharmacists. 
     
X
This ad will auto-close in 10 seconds